Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the previous funding-status notice (lapse in government funding) and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedA banner notice about a lapse in government funding and NIH operations status was added, and the page version updated from 3.4.0 to 3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary display has been added to the page. Minor textual/capitalization tweaks were made (e.g., 'Met QC Criteria' vs 'met QC Criteria' and 'No FEAR Act Data' vs 'data'), and the revision is updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedThe page was updated from revision v3.3.3 to v3.3.4, a minor site revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedNew locations have been added for the study, including sites in Arkansas, California, Illinois, Maryland, North Carolina, Ohio, Texas, and international sites in Queensland, Tasmania, and Victoria, Australia. The revision version is updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedA new site revision label 'Revision: v3.3.2' was added. The previous label 'Revision: v3.2.0' was removed.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.